Significantly More Weight Loss Seen With Tirzepatide Versus Semaglutide
Patients with overweight, obesity receiving tirzepatide significantly more likely to achieve ≥5, ≥10, and ≥15 percent weight loss
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.